IRIS
CAMPOCHIARO, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.548
NA - Nord America 2.425
AS - Asia 1.854
SA - Sud America 276
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 35
OC - Oceania 2
Totale 7.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.313
RU - Federazione Russa 1.223
SG - Singapore 665
CN - Cina 571
RO - Romania 435
IT - Italia 355
BR - Brasile 218
HK - Hong Kong 174
VN - Vietnam 167
DE - Germania 115
BD - Bangladesh 101
FR - Francia 94
CA - Canada 69
GB - Regno Unito 69
SE - Svezia 58
IN - India 45
FI - Finlandia 44
NL - Olanda 31
AT - Austria 27
ES - Italia 26
JP - Giappone 24
MX - Messico 23
PL - Polonia 23
AR - Argentina 22
TR - Turchia 16
ZA - Sudafrica 16
LT - Lituania 14
ID - Indonesia 12
MY - Malesia 12
KR - Corea 10
EC - Ecuador 8
IQ - Iraq 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PY - Paraguay 7
UZ - Uzbekistan 7
NO - Norvegia 6
VE - Venezuela 6
CL - Cile 5
JM - Giamaica 5
KE - Kenya 5
LU - Lussemburgo 5
PH - Filippine 5
TN - Tunisia 5
UA - Ucraina 5
EG - Egitto 4
IE - Irlanda 4
SA - Arabia Saudita 4
CR - Costa Rica 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
AM - Armenia 2
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LC - Santa Lucia 1
MG - Madagascar 1
SI - Slovenia 1
SV - El Salvador 1
Totale 7.141
Salva come PNG Salva come JPEG
Città #
Dallas 936
Singapore 378
Ashburn 231
Moscow 230
San Jose 176
Hong Kong 166
Beijing 117
Milan 86
Shanghai 82
New York 78
Council Bluffs 75
Los Angeles 71
Hefei 58
Ho Chi Minh City 58
Santa Clara 58
Lauterbourg 50
Munich 39
Boardman 36
Nuremberg 33
Hanoi 29
Denver 23
Orem 23
São Paulo 22
Tokyo 21
Phoenix 20
Chicago 19
Montreal 18
Rome 18
Brooklyn 17
Helsinki 17
Poplar 17
Warsaw 17
Toronto 16
Amsterdam 14
Atlanta 14
Guangzhou 14
Johannesburg 14
Lappeenranta 14
Stockholm 14
Buffalo 13
Chennai 13
Frankfurt am Main 13
Houston 13
Turku 13
Falkenstein 12
Boston 11
Da Nang 10
Naples 10
Ankara 9
London 9
Rio de Janeiro 9
City of London 8
Lawrence 8
Mexico City 8
New Delhi 8
Princeton 8
Secaucus 8
Seongnam-si 8
Vaprio d'Adda 8
Vienna 8
Xi'an 8
Cesano Boscone 7
Haiphong 7
Mugnano di Napoli 7
Mumbai 7
Omaha 7
Tashkent 7
Belo Horizonte 6
Bergamo 6
Brescia 6
Cagliari 6
Hangzhou 6
Kuala Lumpur 6
Oslo 6
Porto Alegre 6
Querétaro 6
San Francisco 6
Seattle 6
Shenzhen 6
St Louis 6
Ancona 5
Esch-sur-Alzette 5
Hải Dương 5
Kassel 5
Nairobi 5
Padua 5
Paris 5
Roubaix 5
Tianjin 5
Turin 5
Bexley 4
Columbus 4
Dhaka 4
Kingston 4
Manchester 4
Ottawa 4
Philadelphia 4
Quito 4
Romagnano Sesia 4
Segrate 4
Totale 3.744
Salva come PNG Salva come JPEG
Nome #
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 464
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 446
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 350
Monkeypox in a patient with undifferentiated connective tissue disease 253
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 167
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 160
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 145
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 137
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 137
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 135
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 134
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 126
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 123
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 122
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 120
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 120
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 116
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 116
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 114
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 113
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 112
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 111
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 110
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 109
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 108
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 104
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 104
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 103
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 103
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 103
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 101
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 100
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 99
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 96
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 95
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 93
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 93
VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature 92
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 92
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 92
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 92
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 85
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 82
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 80
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 79
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 77
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation 76
HETEROGENEITY OF CYTOPENIAS IN VEXAS SYNDROME: A SINGLE CENTRE EXPERIENCE 75
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 74
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 74
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review 70
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 69
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review 63
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 56
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 56
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 54
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 53
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 52
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 52
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? 44
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study 27
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience 9
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 8
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 5
Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study 4
Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort 3
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 3
Totale 7.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 3 3 1 8 2 2 5 3 2 2
2022/2023109 19 16 9 0 0 13 28 14 4 0 5 1
2023/2024314 4 13 15 30 25 48 38 38 3 18 28 54
2024/20251.457 55 14 39 62 54 89 585 114 132 90 90 133
2025/20265.143 304 608 673 539 392 141 362 343 1.115 248 223 195
2026/2027299 165 134 0 0 0 0 0 0 0 0 0 0
Totale 7.365